Related content

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

By                            

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 881-885

Spandidos Publications

Access to resources Recommend Favorite

Prognostic outcome in patients treated with tyrosine kinase inhibitors as first-line molecular-targeted therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in Japan

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 601-606

Science Publishers

Access to resources Recommend Favorite

Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients

By Ali Sarfraz  

Tumor Biology, Vol. 32, Iss. 2, 2011-04 ,pp. : 375-380

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Factors of Immunotherapy in Metastatic Renal Cell Carcinoma

By Padrik Peeter  

Medical Oncology, Vol. 20, Iss. 4, 2003-12 ,pp. : 325-334

Humana Press, Inc

Access to resources Recommend Favorite

Metastatic renal cell carcinoma: how to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor

By Sabbatini Roberto   Ortega Cinizia   Procopio Giuseppe   Masini Cristina   Galligioni Enzo   Porta Camillo  

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 831-843

Future Medicine

Access to resources Recommend Favorite